ViiV

RETROVIR

Manufacturer:

ViiV

Retrovir HCPCS:

J3485

HCPCS Code Descriptor:

Injection, zidovudine, 10 mg

Category:

J Code

Retrovir NDCs:

49702-0213-26

Primary Type:

Anti-HIV

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

49702-0213-26

About Retrovir:

RETROVIR is an Anti-HIV drug manufactured by ViiV and administered via the Intravenous route of administration. The J Code: J3485 is aligned to the drug RETROVIR.

ACCESS PRICING AND MORE BY REGISTERING

J3485 Added Date:

January 1, 2001

J3485 Effective Date:

January 1, 2016

J3485 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Retrovir billing and coding information.
Retrovir patient assistance information can be found through ViiVConnect at the URL: https://www.viivconnect.com/
RETROVIR prescribing information can be found at the link below:
Information regarding RETROVIR’s side effects can be found at MedlinePlus